Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raphael Bar-Or

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
Critical Care Medicine|July 9, 2005
Heterogeneity and oxidation status of commercial human albumin preparations in clinical useDavid Bar-Or, Raphael Bar-Or, Leonard T Rael, et al.
Critical Care Medicine|February 27, 2009
Current utilization and radiation dose from computed tomography in patients with traumaKristin Salottolo, Raphael Bar-Or, Matthew Fleishman, et al.
Journal of Neurotrauma|March 26, 2009
Plasma oxidation-reduction potential and protein oxidation in traumatic brain injuryLeonard T Rael, Raphael Bar-Or, Charles W Mains, et al.
Molecular Medicine Reports|April 9, 2011
Raman spectral signatures of human liver perfusates correlate with oxidation reduction potentialRaphael Bar-Or, Leonard T Rael, C Gerald Curtis, et al.
Biochemical and Biophysical Research Communications|April 17, 2007
Combined cupric- and cuprous-binding peptides are effective in preventing IL-8 release from endothelial cells and redox reactionsLeonard T Rael, Nagaraja K R Rao, Gregory W Thomas, et al.
Frontiers in Neurology|July 18, 2019
Plasma Oxidized Albumin in Acute Ischemic Stroke Is Associated With Better OutcomesLeonard T Rael, Jan Leonard, Kristin Salottolo, et al.
Journal of Translational Medicine|December 1, 2020
LMWF5A suppresses cytokine release by modulating select inflammatory transcription factor activity in stimulated PBMCGregory Thomas, Elizabeth Frederick, Lisa Thompson, et al.
Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine|November 21, 2009
Injury severity and serum amyloid A correlate with plasma oxidation-reduction potential in multi-trauma patients: a retrospective analysisLeonard T Rael, Raphael Bar-Or, Kristin Salottolo, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 15, 2006
Severe systemic immune response syndrome, low plasma paraoxonase activity, and a new albumin species in a traumatized patient with Gaucher's diseaseDavid Bar-Or, Leonard T Rael, Raphael Bar-Or, et al.
Journal of Immunoassay & Immunochemistry|May 12, 2015
Anti-Inflammatory Activity in the Low Molecular Weight Fraction of Commercial Human Serum Albumin (LMWF5A)Gregory W Thomas, Leonard T Rael, Charles W Mains, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Critical Care Medicine|July 9, 2005
Heterogeneity and oxidation status of commercial human albumin preparations in clinical useDavid Bar-Or, Raphael Bar-Or, Leonard T Rael, et al.
Critical Care Medicine|February 27, 2009
Current utilization and radiation dose from computed tomography in patients with traumaKristin Salottolo, Raphael Bar-Or, Matthew Fleishman, et al.
Journal of Neurotrauma|March 26, 2009
Plasma oxidation-reduction potential and protein oxidation in traumatic brain injuryLeonard T Rael, Raphael Bar-Or, Charles W Mains, et al.
Molecular Medicine Reports|April 9, 2011
Raman spectral signatures of human liver perfusates correlate with oxidation reduction potentialRaphael Bar-Or, Leonard T Rael, C Gerald Curtis, et al.
Biochemical and Biophysical Research Communications|April 17, 2007
Combined cupric- and cuprous-binding peptides are effective in preventing IL-8 release from endothelial cells and redox reactionsLeonard T Rael, Nagaraja K R Rao, Gregory W Thomas, et al.
Frontiers in Neurology|July 18, 2019
Plasma Oxidized Albumin in Acute Ischemic Stroke Is Associated With Better OutcomesLeonard T Rael, Jan Leonard, Kristin Salottolo, et al.
Journal of Translational Medicine|December 1, 2020
LMWF5A suppresses cytokine release by modulating select inflammatory transcription factor activity in stimulated PBMCGregory Thomas, Elizabeth Frederick, Lisa Thompson, et al.
Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine|November 21, 2009
Injury severity and serum amyloid A correlate with plasma oxidation-reduction potential in multi-trauma patients: a retrospective analysisLeonard T Rael, Raphael Bar-Or, Kristin Salottolo, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 15, 2006
Severe systemic immune response syndrome, low plasma paraoxonase activity, and a new albumin species in a traumatized patient with Gaucher's diseaseDavid Bar-Or, Leonard T Rael, Raphael Bar-Or, et al.
Journal of Immunoassay & Immunochemistry|May 12, 2015
Anti-Inflammatory Activity in the Low Molecular Weight Fraction of Commercial Human Serum Albumin (LMWF5A)Gregory W Thomas, Leonard T Rael, Charles W Mains, et al.
Pageof 5